Literature DB >> 3032088

Rifabutin and rifapentine compared with rifampin against Mycobacterium leprae in mice.

S R Pattyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3032088      PMCID： PMC174672          DOI： 10.1128/AAC.31.1.134

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Activity of three new rifamycin derivates on the experimental infection by Mycobacterium leprae.

Authors:  S R Pattyn; E J Saerens
Journal:  Ann Soc Belg Med Trop       Date:  1977

2.  Rapid bactericidal effect of rifampin on Mycobacterium leprae.

Authors:  C C Shepard; L Levy; P Fasal
Journal:  Am J Trop Med Hyg       Date:  1972-07       Impact factor: 2.345

3.  Activity of ansamycin against Mycobacterium leprae in mice.

Authors:  R C Hastings; R R Jacobson
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

4.  Comparison of the sensitivity of mycobacteria to the cyclopentyl rifamycin DL473 and rifampicin.

Authors:  M D Yates; C H Collins
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

5.  Biological activity of a new class of rifamycins. Spiro-piperidyl-rifamycins.

Authors:  A Sanfilippo; C Della Bruna; L Marsili; E Morvillo; C R Pasqualucci; G Schioppacassi; D Ungheri
Journal:  J Antibiot (Tokyo)       Date:  1980-10       Impact factor: 2.649

6.  [Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].

Authors:  C Truffot-Pernot; J Grosset; R Bismuth; H Lecoeur
Journal:  Rev Fr Mal Respir       Date:  1983

7.  In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.

Authors:  C L Woodley; J O Kilburn
Journal:  Am Rev Respir Dis       Date:  1982-09

8.  Physiological disposition of a series of rifamycins in rat: a comparative study.

Authors:  A Assandri; T Cristina; L Moro
Journal:  J Antibiot (Tokyo)       Date:  1978-09       Impact factor: 2.649

9.  A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.

Authors:  S R Pattyn
Journal:  Arzneimittelforschung       Date:  1982

10.  Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.

Authors:  M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
  10 in total
  2 in total

1.  Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.

Authors:  Ming Xu; Yan Ning Zhou; Beth P Goldstein; Ding Jun Jin
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 2.  Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; A Fitton
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.